The renin angiotensin system and Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 903, Issue , 2000, Pages 437-441

  Amouyel, Philippe ^a   Richard, Florence ^a   Berr, Claudine ^b   David Fromentin, Isabelle ^c   Helbecque, Nicole ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Hôpitaux Universitaires Henri Mondor   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; RAS PROTEIN;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; BLOOD LEVEL; CARDIOVASCULAR RISK; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENVIRONMENTAL FACTOR; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HEREDITY; HOMEOSTASIS; HUMAN; HYPERTENSION; LIPID METABOLISM; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR DISEASE;

EID: 0034117274     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06395.x     Document Type: Conference Paper

References (24)

1. 1. PASQUIER, F. & D. LEYS. 1997. Why are stroke patients prone to develop dementia? J. Neurol. 244: 135-142.
2. 2. SNOWDON, D.A., L.H. GREINER, J.A. MORTIMER et al. 1997. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277: 813-817.
3. 3. HOFMAN, A., A. OTT, M.M. BRETELER et al. 1997. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 349: 151-154.
4. 4. SPARKS, D.L., J.C. HUNSAKER, S.W. SCHEFF et al. 1990. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol. Aging 11: 601-607.
5. 5. SKOOG, I., B. LERNFELT, S. LANDAHL et al. 1996. Fifteen-year longitudinal study of blood pressure and dementia. Lancet 347: 1141-1145.
6. 6. WEISGRABER, K.H. & R.W. MAHLEY. 1996. Human apolipoprotein E: the Alzheimer's disease connection. FASEB J. 10: 1485-1494.
7. 7. RIGAT, B., C. HUBERT, F. ALHENC-GELAS et al. 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86: 1343-1346.
8. 8. COSTEROUSSE, O., J. ALLEGRINI, M. LOPEZ & F. ALHENC-GELAS. 1993. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem. J. 290: 33-40.
9. 9. CAMBIEN, F., O. POIRIER, L. LECERF et al. 1992. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641-644.
10. 10. HAMON, M., C. AMANT, C. BAUTERS et al. 1996. ACE polymorphism, a genetic predictor of occlusion after coronary angioplasty. Am. J. Cardiol. 78: 679-681.
11. 11. AMANT, C., C. BAUTERS, J.C. BODART et al 1997. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation 96: 56-60.
12. 12. WRIGHT, J.W. & J.W. HARDING. 1994. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci. Biobehav. Rev. 18: 21-53.
13. 13. ERDOS, E.G. & R. SKIDGEL. 1987. The angiotensin I-converting enzyme. Lab. Invest. 56: 345-348.
14. 14. CROOG, S.H., S. LEVINE, M. TESTA et al. 1986. The effects of antihypertensive therapy on the quality of life. N. Engl. J. Med. 314: 1657-1664.
15. 15. BARNES, N.M., C.H. CHENG, B. COSTALL et al. 1991. Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease. Eur. J. Pharmacol. 200: 289-292.
16. 16. ARREGUI, A., E.K. PERRY, M. ROSSOR & B.E. TOMLINSON. 1982. Angiotensin converting enzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas. J. Neurochem. 38: 1490-1492.
17. 17. AMOUYEL, P., F. RICHARD, D. COTTEL et al. 1996. The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci. Lett. 217: 203-205.
18. 18. KEHOE, P.G., C. Russ, S. MCILORY et al. 1999. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat. Genet. 21: 71-72.
19. 19. TYSOE, C., D. GALINSKY, D. ROBINSON et al. 1997. Analysis of alpha-1 antichymotrypsin, presenilin-1, angiotensin-converting enzyme, and methylenetetrahydrofolate reductase loci as candidates for dementia. Am. J. Med. Genet. 74: 207-212.
20. 20. SCACCHI, R., L. DE BERNARDINI, E. MANTUANO et al. 1998. DNA polymorphisms of apolipoprotein B and angiotensin I-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 9: 186-190.
21. 21. CHAPMAN, J., N. WANG, T.A. TREVES et al. 1998. ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke 29: 1401-1404.
22. 22. AGERHOLM-LARSEN, B., B.G. NORDESTGAARD, R. STEFFENSEN et al. 1997. ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation 95: 2358-2367.
23. 23. GALINSKY, D., C. TYSOE, C.E. BRAYNE et al. 1997. Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis 129: 177-183.
24. 24. SCHACHTER, F., L. FAURE-DELANEF, F. GUENOT et al. 1994. Genetic associations with human longevity at the APOE and ACE loci. Nat. Genet. 6: 29-32.